dc.contributor.author |
Kouloulias, V |
en |
dc.contributor.author |
Matsopoulos, G |
en |
dc.contributor.author |
Kouvaris, J |
en |
dc.contributor.author |
Dardoufas, C |
en |
dc.contributor.author |
Bottomley, A |
en |
dc.contributor.author |
Varela, M |
en |
dc.contributor.author |
Uzunoglu, N |
en |
dc.contributor.author |
Antypas, C |
en |
dc.contributor.author |
Metafa, A |
en |
dc.contributor.author |
Moulopoulos, A |
en |
dc.contributor.author |
Sandilos, P |
en |
dc.contributor.author |
Vlahos, L |
en |
dc.date.accessioned |
2014-03-01T01:19:28Z |
|
dc.date.available |
2014-03-01T01:19:28Z |
|
dc.date.issued |
2003 |
en |
dc.identifier.issn |
0360-3016 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/15513 |
|
dc.subject |
Disodium pamidronate |
en |
dc.subject |
EORTC QLQ-C30 quality-of-life questionnaire |
en |
dc.subject |
Image-processing techniques |
en |
dc.subject |
Osteolytic metastases |
en |
dc.subject |
Prognostic factors |
en |
dc.subject |
Radiotherapy |
en |
dc.subject.classification |
Oncology |
en |
dc.subject.classification |
Radiology, Nuclear Medicine & Medical Imaging |
en |
dc.subject.other |
Breast cancers |
en |
dc.subject.other |
Biochemistry |
en |
dc.subject.other |
Diseases |
en |
dc.subject.other |
Image processing |
en |
dc.subject.other |
Radiography |
en |
dc.subject.other |
Radiotherapy |
en |
dc.subject.other |
Oncology |
en |
dc.subject.other |
alkaline phosphatase bone isoenzyme |
en |
dc.subject.other |
calcium |
en |
dc.subject.other |
creatinine |
en |
dc.subject.other |
hydroxyproline |
en |
dc.subject.other |
pamidronic acid |
en |
dc.subject.other |
paracetamol |
en |
dc.subject.other |
arthralgia |
en |
dc.subject.other |
article |
en |
dc.subject.other |
asthenia |
en |
dc.subject.other |
bone metastasis |
en |
dc.subject.other |
bone pain |
en |
dc.subject.other |
bone radiography |
en |
dc.subject.other |
breast cancer |
en |
dc.subject.other |
calcium urine level |
en |
dc.subject.other |
cancer chemotherapy |
en |
dc.subject.other |
cancer radiotherapy |
en |
dc.subject.other |
chill |
en |
dc.subject.other |
clinical article |
en |
dc.subject.other |
clinical trial |
en |
dc.subject.other |
controlled clinical trial |
en |
dc.subject.other |
controlled study |
en |
dc.subject.other |
creatinine urine level |
en |
dc.subject.other |
female |
en |
dc.subject.other |
flu like syndrome |
en |
dc.subject.other |
follow up |
en |
dc.subject.other |
heart arrhythmia |
en |
dc.subject.other |
heart palpitation |
en |
dc.subject.other |
histogram |
en |
dc.subject.other |
human |
en |
dc.subject.other |
hydroxyproline urine level |
en |
dc.subject.other |
hypercalcemia |
en |
dc.subject.other |
hypocalcemia |
en |
dc.subject.other |
hypophosphatemia |
en |
dc.subject.other |
linear accelerator |
en |
dc.subject.other |
multimodality cancer therapy |
en |
dc.subject.other |
multivariate analysis |
en |
dc.subject.other |
myalgia |
en |
dc.subject.other |
osteolysis |
en |
dc.subject.other |
phase 1 clinical trial |
en |
dc.subject.other |
phase 2 clinical trial |
en |
dc.subject.other |
priority journal |
en |
dc.subject.other |
quality of life |
en |
dc.subject.other |
questionnaire |
en |
dc.subject.other |
radiation dose |
en |
dc.subject.other |
rank sum test |
en |
dc.subject.other |
side effect |
en |
dc.subject.other |
statistical significance |
en |
dc.subject.other |
Adult |
en |
dc.subject.other |
Aged |
en |
dc.subject.other |
Bone Neoplasms |
en |
dc.subject.other |
Breast Neoplasms |
en |
dc.subject.other |
Combined Modality Therapy |
en |
dc.subject.other |
Diphosphonates |
en |
dc.subject.other |
Female |
en |
dc.subject.other |
Follow-Up Studies |
en |
dc.subject.other |
Humans |
en |
dc.subject.other |
Infusions, Intravenous |
en |
dc.subject.other |
Middle Aged |
en |
dc.subject.other |
Quality of Life |
en |
dc.subject.other |
Radiographic Image Interpretation, Computer-Assisted |
en |
dc.subject.other |
Treatment Outcome |
en |
dc.title |
Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: Clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/S0360-3016(03)00525-X |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1016/S0360-3016(03)00525-X |
en |
heal.language |
English |
en |
heal.publicationDate |
2003 |
en |
heal.abstract |
Purpose: To evaluate the clinical improvement and radiographically monitor the effect of local radiotherapy in conjunction with disodium pamidronate (DP) on metastatic osteolytic disease. Methods and Materials: Thirty-three patients with osteolytic metastasis from advanced breast cancer received radiotherapy with a 6-MV linear accelerator up to a dose of 30 Gy (3 Gy/fraction, 5 d/wk) combined with 24 monthly sessions of a 180-mg DP infusion. Conventional X-rays were obtained during the first six sessions of DP treatment, retaining the same settings for each exposure. The analysis of the image attributes was based on measuring the first-order statistics of the mean value and energy of gray-level histograms in the osteolytic region. Results: The 6-month measurements compared with baseline showed statistically significant differences (p < 0.01, Wilcoxon test) in energy of gray-level histogram (-10.8%), mean value of gray-level histogram (+9.5%), pain score (-5.8 points), Eastern Cooperative Oncology Group status (-2.4 points), urine hydroxyproline/creatinine ratio (-41.7%), urine calcium/creatinine ratio (-58.8%), and bone alkaline phosphatase (-42.4%). Quality of life as determined by the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (version 3) also improved. During follow-up, 88% of patients had complete and 12% partial responses (International Union Against Cancer radiologic criteria). On multivariate analysis, greater changes in the mean value of the gray-level histogram and negative nodal status were predictors for a reduction in the number of skeletal complications after therapy. Flu-like syndrome occurred in 13 patients (39%) and was well managed with mild antipyretics. Conclusion: Image-processing in plain radiographs offers an objective way to assess recalcification. The image-processing indexes, along with the measurements of performance status, quality of life, and biochemical markers, improved significantly. Local radiotherapy combined with long-term high-dose DP up to 180 mg is tolerable and has a high therapeutic response. (C) 2003 Elsevier Inc. |
en |
heal.publisher |
ELSEVIER SCIENCE INC |
en |
heal.journalName |
International Journal of Radiation Oncology Biology Physics |
en |
dc.identifier.doi |
10.1016/S0360-3016(03)00525-X |
en |
dc.identifier.isi |
ISI:000184676100024 |
en |
dc.identifier.volume |
57 |
en |
dc.identifier.issue |
1 |
en |
dc.identifier.spage |
143 |
en |
dc.identifier.epage |
157 |
en |